摘要
目的观察脑脉泰胶囊治疗缺血性脑血管病后遗症的临床疗效。方法选取106例患者根据简单随机抽样法分为治疗组和对照组各53例。治疗组给予脑脉泰胶囊1.0g,3次/d;对照组给予曲克芦丁片120mg,3次/d,连用2个月,观察疗效。结果治疗组总有效48例(90.57%),对照组总有效41例(77.36%)治疗组疗效明显优于对照组,差异有统计学意义(P〈0.05)。结论脑脉泰胶囊治疗缺血性脑血管病后遗症疗效较好,不良反应较少。
Objective To observe the clinical effect of Naomaitai capsule for patients with ischemic stroke sequel. Methods A hundred and six patients were randomized into treatment group and control group and each group had 53 patients. The treatment group was treated with Naomaitai capsule (1.0 gram, three times a day, orally) ; the control group was treated with Qukeluding tablet (120 rag, three times a day, orally). The treatment period was 2 months. Results Compared with the control group, Naomaitai treatment group had better curative effect. Conclusion Naomaitai capsule provides a safe and satisfactory effect on patients with ischemic stroke sequel.
出处
《中国医药》
2009年第1期46-47,共2页
China Medicine